Jump to Main Content

Highlights of ASH


Attendees will receive access to all presentations and live experiences on the virtual platform through April 2. The schedule is organized by featured weeks and may have relevance to your specific region.

  • Region Relevancy Program Topic Speaker(s)
    North America Acute Myeloid Leukemia Margaret Kasner, MD
    Thomas Jefferson University
    Bleeding Disorders Alice Ma, MD
    University of North Carolina
    Chronic Lymphocytic Leukemia John Burke, MD
    Rocky Mountain Cancer Center
    Chronic Myeloid Leukemia including Myeloproliferative Neoplasms Vivian Oehler, MD
    Fred Hutchinson Cancer Research Center
    COVID-19 and Hematology (Acute Manifestations and Thrombosis/Bleeding)

    Neil Zakai, MD
    University of Vermont

    Deborah Siegal, MD
    McMaster University

    Jean Connors, MD
    Brigham & Women's Hospital

    ITP/TTP and aHUS Camila Masias, MD
    Baptist Health South Florida
    Lymphoma Christopher Flowers, MD
    MD Anderson Cancer Center
    Myelodysplastic Syndromes Hetty Carraway, MD
    Cleveland Clinic
    Myeloma & Plasma Cell Dyscrasia Shaji Kumar, MD
    Mayo Clinic
    Red Blood Cells, Anemia, and Iron Marc Kahn, MD, MBA
    University of Nevada Las Vegas
    Thrombosis Julie Jaffray, MD
    Children's Hospital Los Angeles
    Transfusion Medicine Cassandra Josephson, MD
    Emory University

    Sickle Cell Disease and Thalassemia

    Thalassemia and sickle cell disease (SCD) are common in the Mediterranean and African countries. In this session, Dr. Alexis Thompson will discuss how current and future therapies targeting the disease pathophysiology are evolving.

    Alexis Thompson, MD, MPH
    Northwestern University
     ALL Ph+ Elias Jabbour, MD
    MD Anderson Cancer Center

    Managing Thalassemia Throughout Asia: Overcoming the Obstacles

    In the vast expanse of land and the many countries that occupy Asia, haemoglobinopathies are widely prevalent in a variable fashion; unfortunately, the standard of care is not proportionate to the burden of disease. Some regions with low prevalence have good standards of care for patients, and regions with high prevalence seem to be struggling even with basic care. Dr. Anuja P. Premawardhena will touch on how regional cooperation can be a way out of this quagmire.

    Anuja P. Premawardhena, MD
    University of Kelaniya - Sri Lanka
    Latin America

    Regional Registries in Latin America

    The session will focus on the ongoing efforts to create national and regional registries, as well as on the results of those efforts and future growth of those collaborative works.

    Virginia Abello, MD
    Hospital de San José

    Carolina Pavlovsky, MD
    Fundaleu Hospital and Clinical Research Center

    Management of Hodgkin Lymphoma in the First Relapse John Kuruvilla, MD
    Princess Margaret Cancer Centre

  • All programming will be delivered in Eastern time.

    Date Time Content Release or Live Experience
    Monday, March 1 11:00 a.m. Release of Pre-Recorded Content Relevant to North America
    Wednesday, March 3 6:00 p.m.

    Live Q&A Session: Leukemia Community Night

    • AML
    • MDS
    Thursday, March 4 6:00 p.m.

    Live Q&A Session: Lymphoma Community Night

    • CLL
    • Lymphoma
     Tuesday, March 4 7:15 p.m. Live Product Theater: A New Combination Therapy for Previously Treated Follicular Lymphoma*
    Tuesday, March 9 6:00 p.m. Live Q&A Session: Plasma Cell Dyscrasia & MPN Community Night
    Tuesday, March 9 7:15 p.m. Live Product Theater: A Treatment Option for Patients with Myelofibrosis*
    Wednesday, March 10 6:00 p.m.

    Live Q&A Session: Coagulation Disorders Community Night

    • COVID-19 & Hematology
    • Bleeding
    • Thrombosis
    • ITP/TTP and aHUS
     Thursday, March 11 6:00 p.m.

    Live Q&A Session: Transfusion Medicine & Red Blood Cell Disorders Community Night

    • Hemoglobinopathies and Sickle Cell Disease
    • Red Blood Cells Disorders
    • Transfusion Medicine
    Monday, March 15 11:00 a.m. Release of Pre-Recorded Content Relevant to the Mediterranean
    Wednesday, March 17 12:00 p.m. Live Q&A Session: Haemoglobinopathy and ALL in the Mediterranean
    Monday, March 22 11:00 a.m. Release of Pre-Recorded Content Relevant to Asia-Pacific
    Wednesday, March 24 6:00 p.m. Live Q&A Session: Haemoglobinopathy and Thalassemia in Asia-Pacific
    Monday, March 29 11:00 a.m. Release of Pre-Recorded Content Relevant to Latin America
    Tuesday, March 30 3:00 p.m. Live Satellite Symposia: Relevance of Deep Response in CLL*
    Wednesday, March 31 6:00 p.m. Live Q&A Session: Regional Registries and Hodgkin Lymphoma in Latin America 
    Thursday, April 1 3:00 p.m. Live Satellite Symposia: Novel Treatments in AML*
    * Product Theaters and Satellite Symposia are industry-sponsored programs in conjunction with the 2021 Highlights of ASH. These events are not part of the official ASH meeting program and are planned solely by the sponsoring company.